Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS)

Journal of Neuroimmunology

Volumn 73, Issue 1-2, 1997, Pages 28-36

  Gregson, N A ^a   Rees, J H ^a   Hughes, R A C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

anti ganglioside; Campylobacter jejuni; GM1; Guillain Barre syndrome; IgG; lipopolysaccharide

Indexed keywords

AUTOANTIBODY; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; IMMUNOGLOBULIN G2; LIPOPOLYSACCHARIDE;

ADULT; ARTICLE; CAMPYLOBACTER JEJUNI; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE RESPONSE; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIBODIES; CAMPYLOBACTER JEJUNI; CHOLERA TOXIN; FEMALE; G(M1) GANGLIOSIDE; HUMANS; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY;

EID: 0031042095     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00162-2     Document Type: Article

References (50)

1. Aspinall, G.O., Fujimoto, S., McDonald, A.G., Pang, H., Kurjanczyk, L.A. and Penner, J.L. (1994a) Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré Syndrome patients mimic human gangliosides in structure. Infect. Immun. 62, 2122-2125.
2. Aspinall, G.O., McDonald, A.G., Raju, T.S., Pang, H., Moran, A.P. and Penner, J.L. (1993) Chemical structures of the core regions of Campylobacter jejuni serotypes O;1, O:4, O:23, and O:36 lipopolysaccharides. Eur. J. Biochem. 213, 1017-1027.
3. Aspinall, G.O., McDonald, A.G., Pang, H., Kuranczyk, L.A. and Penner, J.L. (1994b) Lipopolysaccharides of Campylobacter jejuni serotype O:19: structure of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochem 33, 241-249.
4. Blake, D.C. and Russell, R.G. (1993) Demonstration of lipopolysaccharide with O-polysaccharide chains among heat-stable serotypes of Campylobacter jejuni by silver staining of polyacrylamide gels. Infect. Immun. 61, 5384-5387.
5. Boucquey, D., Sindic, C.J., Lamy, M., Delmee, M., Tomasi, J.P. and Laterre, E.C. (1991) Clinical and serological studies in a series of 45 patients with Guillain-Barré syndrome. J. Neurol. Sci. 104, 56-63.
6. Chiba, A., Kusonoki, S., Shimizu, T. and Kanazawa, I. (1992) serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31, 677-679.
7. Cooper, L.J.N., Schimenti, J.C., Glass, D.D. and Greenspan, N.S. (1991) H chain C domains influence the strength of binding of IgG for streptococcal group A carbohydrate. J. Immunol. 146, 2659-2663.
8. Daikoku, T., Kawaguchi, M., Takama, K. and Suzuki, S. (1990) Partial purification and characterization of the enterotoxin produced by Campylobacter jejuni. Infect. Immun. 58, 2414-2419.
9. Enders, U., Karch, H., Toyka, K.V., Michels, M., Zielasek, J., Pette, M., Heesemann, J. and Hartung, H.-P. (1993) The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann. Neurol. 34, 136-144.
10. Greenspan, N.S. and Cooper, L.J.N. (1995) Complementarity, specificity and the nature of epitopes and paratopes in multivalent interactions. Immunol. Today, 16, 226-230.
11. Gregson, N.A., Jones, D., Thomas, P.K. and Willison, H.J. (1991) Acute motor neuropathy with antibodies to GM1 ganglioside. Neurol. 238, 447-451.
12. Gregson, N.A., Koblar, S. and Hughes, R.A. (1993) Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q. J. Med. 86, 111-117.
13. Griffin, J.W. and Ho, T.W.-H. (1993) The Guillain-Barré syndrome at 75: the Campylobacter connection. Ann. Neurol. 34, 125-127.
14. Hardin, J.A. (1986) The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthrit. Rheum. 29, 457-460.
15. Hardy, R.R. and Hayakawa, K. (1994) CD5 B cells, a fetal B cell lineage. Adv. Immunol. 55, 297-339.
16. Ho, T.W., Mishu, B., Li, C.Y., Gao, C.Y., Cornblath, D.R., Griffin, J.W., Asbury, A.K., Blaser, M.J. and McKhann, G.M. (1995) Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118, 597-605.
17. Illa, I., Ortiz, N., Gallard, E., Juarez, C., Grau, J.M. and Dalakas, M.C. (1995) Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann. Neurol. 38, 218-221.
18. Ilyas, H.A., Willison, H.J., Quarles, R.H., Jungalwala, F.B., Cornblath, D.R., Trapp, B.D., Griffin, D.E., Griffin, J.W. and McKhann, G.M. (1988) Serum antibodies to gangliosides in Guillain Barré Syndrome. Ann. Neurol. 23, 440-447.
19. Kuroki, S., Saida, T., Nukina, M., Haruta, T., Yoshioka, M. and Kobayashi, Y. (1993) Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues. Ann. Neurol. 33, 243-247.
20. Lee, K.W., Inghirami, G., Spatz, L., Knowles, D.M. and Latov, N. (1991) The B-cells that express anti-MAG antibodies in neuropathy and non-malignant IgM monoclonal gammopathy belong to the CD5 subpopulation. J. Neuroimmunol. 31, 83-88.
21. McCardell, B.A., Madden, J.M. and Lee, E.C. (1984) Production of cholera-like toxin by Campylobacter jejuni/coli. Lancet 1, 448-449.
22. McKahnn, G.M., Cornblath, D.R., Griffin, J.W., Ho, T.W., Li, C.Y., Jiang, Z., Wu, H.S., Zhaori, G., Liu, T.C., Jou, L.P., Gao, C.Y., Mao, J.Y., Blaser, M.J., Mishu, B. and Asbury, A.K. (1993) Acute motor axonal neuropathy: a frequent cause of acute flaccid motor paralysis in China. Ann. Neurol. 33, 333-342.
23. Mishu, B. and Blaser, M.J. (1993) Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome. Clin. Infect. Dis. 17, 104-108.
24. Mishu, B., Ilyas, A.A., Koski, C.L., Vriesendorp, F., Cook, S.D., Mithen, F.A. and Blaser, M.J. (1993) Serologic evidence of previous Campylobacter jejuni infection in patients with Guillain-Barré syndrome. Ann. Int. Med. 118, 947-953.
25. Moran, A.P., Rietschel, E.T., Kosunen, T.U. and Zähringer, U. (1991). Chemical characterisation of Campylobacter jejuni lipopolysaccharide containing N-acetyl neuraminic acid and 2,3,-diamino-2,3-dideoxy-D-glucose. J. Bacteriol. 173, 618-626.
26. Mizutamari, R.K., Wiegandt, H. and Nores, G.A. (1994) Characterisation of anti-ganglioside antibodies present in normal human plasma. J. Neuroimmunol. 50, 215-220.
27. Nobile-Orazio, E., Carpo, M., Meucci, E., Grassi, M.P., Capitani, E., Sciacco, M., Mangoni, A. and Scarlato, G. (1992) Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies. J. Neurol. Sci. 109, 200-206.
28. Ogino, M., Orazio, N. and Latov, N. (1995) IgG anti-GM1 antibodies from patients with acute motor neuropathy are predomiantly of the IgG1 and IgG3 subclasses. J Neuroimmunol. 58, 77-80.
29. Oomes, P.G., Jacobs, B.C., Hazenberg, M.P.H., Bänffer, J.R.J. and van der Meché, F.G.A. (1995) Anti-GM1 antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry. Ann. Neurol. 38, 170-175.
30. Quarles, R.H., Ilyas, A.A. and Willison, H.J. (1990) Antibodies to gangliosides and myelin proteins in Guillain-Barré syndrome. Ann. Neurol. 27, Suppl. S48-S52.
31. Rees, J.H., Gregson, N.A., Griffiths, P.L., Hughes, R.A.C. and Hughes, R.A. (1993) Campylobacter jejuni and Guillain-Barré syndrome. Q. J. Med. 86, 623-634.
32. Rees, J.H., Gregson, N.A. and Hughes, R.A.C. (1995a) Anti-ganglioside antibodies in Guillain Barré syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol. 38, 809-816.
33. Rees, J.H., Soudain, S.A., Gregson, N.A. and Hughes, R.A.C. (1995b) Campylobacter jejuni infection and Guillain-Barré syndrome. New Eng. J. Med. 333, 1374-1379.
34. Speed, B.R., Kaldor, J., Watson, J., Newton-John, H., Tee, W., Noonan, D. and Dwyer, B.W. (1987) Campylobacter jejuni/Campylobacter coli-associated Guillain-Barré syndrome. Med. J. Aust. 147, 13-16.
35. Steinhoff, U., Burkhart, C., Amheiter, H., Hengartner, H. and Zinkernagel, R. (1994) Virus or hapten-carrier complex can activate autoreactive B cells by providing linked T help. Eur. J. Immunol. 24, 773-776.
36. Tan, E.M. (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44, 93-151.
37. Tsuda, N., Negoro, K., Morimatsu, M., Saito, K. and Yuki, N. (1995) [Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni enteritis]. [Japanese]. Rinsho Shinkeigaku-Clinical Neurology 35, 208-210.
38. Van den Berg, L.H., Marrink, J., deJager, A.E.J., deJong, H.J., vanImhoff, G.W., Latov, N. and Sadiq, S.A. (1992) Anti-GM1 antibodies in patients with Guillain-Barré syndrome. J. Neurol. Neurosurg. Psych. 55, 8-11.
39. Visser, L.H., van der Meché, F.G.A., van Doorn, P.A., Meulstee, J., Jacobs, B.C., Oomes, P.G., Kleyweg, R.P. and Dutch GBS Group (1995) Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Brain 118, 841-847.
40. + human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing. Autoimmun. 19, 39-48.
41. Walsh, F.S., Cronin, M., Koblar, S., Doherty, P., Winer, J., Leon, A. and Hughes, R.A.C. (1991) Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J. Neuroimmunol. 34, 43-51.
42. Willison, H.J. and Kennedy, P.G.E. (1993) Gangliosides and bacterial toxins in Guillain-Barré syndrome. J. Neuroimmunol. 46, 105-112.
43. Willison, H.J. and Veitch, J. (1994) Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J. Neuroimmunol. 50, 159-165.
44. Willison, H.J., Veitch, J., Paterson, G. and Kennedy, P.G.E. (1993) Miller Fisher Syndrome is associated with serum antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psychiat. 56, 204-206.
45. Winer, J.B., Hughes, R.A.C., Anderson, M.J., Jones, D.M., Kangro, H. and Watkins, R.F.P. (1988) A prospective study of acute idiopathic neuropathy. II. Antecedent events. J. Neurol. Neurosurg. Psych. 51, 613-618.
46. Yuki, N., Handa, S., Taki, T., Kasama, T., Takahashi, M., Saito, K. and Miyatake, T. (1992) Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barré syndrome: molecular mimicry between ganglioside GM1, and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni. Biomed. Res. 13, 451-453.
47. Yuki, N., Taki, T., Inagaki, F., Kasama, T., Takahashi, M., Saito, K., Handa, S., Miyatake, T. and Insagaki, F. (1993) A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178, 1771-1775.
48. Yuki, N., Taki, T., Takahashi, M., Saito, K., Tal, T., Miyatake, T. and Handa, S. (1994a) Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope. Infect. Immun. 62, 2101-2103.
49. Yuki, N., Taki, T., Takahashi, M., Saito, K., Yoshino, H., Tai, T., Handa, S. and Miyatake, T. (1994b) Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients Fisher's syndrome. Ann. Neurol. 36, 791-793.
50. Yuki, N., Yoshino, H., Sato, S. and Miyatake, T. (1990) Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis [see comments]. Neurol. 40, 1900-1902.